Lifeboat Foundation

Is the Executive Director of the Innovative Genomics Institute (https://innovativegenomics.org/people/brad-ringeisen/), an organization founded by Nobel Prize winner Dr. Jennifer Doudna, on the University of California, Berkeley campus, whose mission is to bridge revolutionary gene editing tool development to affordable and accessible solutions in human health and climate.

Dr. Ringeisen is a physical chemist with a Ph.D. from the University of Wisconsin-Madison, a Bachelor of Science in chemistry from Wake Forest University, a pioneer in the field of live cell printing, and an experienced administrator of scientific research and product development.

Continue reading “Dr. Brad Ringeisen, Ph.D. — Executive Director, Innovative Genomics Institute (IGI)” »

After using the Whisker Litter-Robot 4, I will never return to a regular litter box. The insight it gives me into Norbert’s overall health and the daily cleaning makes it completely worth it. Just be patient with the setup process and with your cat learning a new routine. Norbert’s opinion also upholds the new litter box since he was able to transition pretty seamlessly and gets to have a clean litter box every single time.

Also: This army robot dog is part of a bigger battle for brain-machine interface tech

The Whisker Litter-Robot 4 is no doubt expensive, but the company also offers the previous generation Litter-Robot 3 for a bit cheaper at $549. It’s definitely an investment, but this is a type of automated technology I can get behind.

The first “AI incident” almost caused global nuclear war. More recent AI-enabled malfunctions, errors, fraud, and scams include deepfakes used to influence politics, bad health information from chatbots, and self-driving vehicles that are endangering pedestrians.

The worst offenders, according to security company Surfshark, are Tesla, Facebook, and OpenAI, with 24.5% of all known AI incidents so far.

In 1983, an automated system in the Soviet Union thought it detected incoming nuclear missiles from the United States, almost leading to global conflict. That’s the first incident in Surfshark’s report (though it’s debatable whether an automated system from the 1980s counts specifically as artificial intelligence). In the most recent incident, the National Eating Disorders Association (NEDA) was forced to shut down Tessa, its chatbot, after Tessa gave dangerous advice to people seeking help for eating disorders. Other recent incidents include a self-driving Tesla failing to notice a pedestrian and then breaking the law by not yielding to a person in a crosswalk, and a Jefferson Parish resident being wrongfully arrested by Louisiana police after a facial recognition system developed by Clearview AI allegedly mistook him for another individual.

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

Continue reading “ApoB: Is Lower Always Better?” »

Prof. Yossi Buganim and his research team at the Faculty of Medicine at the Hebrew University of Jerusalem have achieved a groundbreaking milestone in the field of cell reprogramming. Their latest study, published in Nature Communications, reveals a remarkable breakthrough in converting skin samples into functional human placenta cells. This achievement has significant implications for understanding pregnancy development, studying pregnancy-related diseases, and advancing cell therapies.

The research opens new avenues for investigating the causes of infertility, complications during pregnancy, and long-term health implications for both mothers and babies.

Reprogramming cells to assume new identities has been a focus of Prof. Buganim’s lab, which utilizes specialized proteins to modify gene expression. By transforming skin cells into other cell types, the team enables the study of specific diseases and the potential development of cell-based therapies. However, accessing cells from the placenta, a critical organ in pregnancy, has long been a challenge due to technical and ethical constraints.

Malaria, a mosquito-borne infectious disease mostly found in tropical climates, is now on American shores. Late Monday, the Centers for Disease Control and Prevention announced a spat of cases — one in Texas and four in Florida — discovered in May and June that were locally acquired versus acquired while traveling abroad. This is the first time this has happened since 2003.

The CDC said that all five patients received treatment and are recovering, but the agency remains on alert for any new cases. While malaria was once a public health threat in the US, its presence was eradicated in the early 1950s. The last major outbreak was in 2003 with eight patients in Palm Beach County, Florida, all of whom had significant outdoor exposure.

For now, the CDC says the risk of catching malaria in the US “remains extremely low.” However, the instance shouldn’t be taken lightly, especially as many of us will be spending more time outdoors and traveling during the summer. Here’s what you need to know.

The Europe Union is introducing “crash test” systems for artificial intelligence to ensure new innovations are safe before they hit the market.

The trade bloc launched four permanent testing and experimental facilities across Europe on Tuesday, having injected €220 million ($240 million) into the project. The centers, which are virtual and physical, will from next year give technology providers a space to test AI and robotics in real-life settings within manufacturing, health care, agriculture and food, and cities.

What you can do to right now in just a few minutes to help secure the grid. See special quest producer David Tice explain how he is using the Grid Down Power Up movie, narrated by Dennis Quad to give us hope for a secure future. Do it for the kids!

Grid Down Power Up: https://griddownpowerup.com/

Continue reading “Grid Down Power Up — What You Can Do with David Tice” »

Most stroke patients taking the anticoagulant warfarin were no more likely than those not on the medication to experience a brain bleed when undergoing a procedure to remove a blood clot, UT Southwestern Medical Center researchers report in a new study. The findings, published in JAMA, could help doctors better gauge the risk of endovascular thrombectomy (EVT), potentially expanding the pool of eligible patients for this mainstay stroke treatment.

Warfarin is a type of blood thinner commonly used to prevent stroke because of heart conditions such as atrial fibrillation. Although not very common, patients taking warfarin may still experience a stroke. In clinical practice, it’s very possible that some physicians may withhold an endovascular thrombectomy because patients have been treated with warfarin before their strokes.

Our study could increase the number of patients for whom this lifesaving and function-saving surgery would be appropriate, said study leader Ying Xian, M.D., Ph.D., Associate Professor of Neurology and in the Peter O’Donnell Jr. School of Public Health at UT Southwestern. Dr. Xian is also Section Head of Research, Stroke and Cerebrovascular Diseases in the Department of Neurology at UTSW.